A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: A clinician's guide

Oncologist

Volumn 18, Issue 2, 2013, Pages 180-189

  Chu, Amy ^a   Genden, Eric ^a   Posner, Marshall ^a   Sikora, Andrew ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Counseling; Human papillomavirus testing; Oropharyngeal cancer; Psychosocial outcomes

Indexed keywords

PROTEIN E6; PROTEIN E7; PROTEIN P16; PROTEIN P53;

ANXIETY; ARTICLE; CONDOM; CONFUSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TOBACCO; UTERINE CERVIX CANCER; WART VIRUS;

FEMALE; HEAD AND NECK NEOPLASMS; HEALTH EDUCATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 84874357518     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0200     Document Type: Article

References (88)

1. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: Is it time to change our treatment paradigms? J Natl Compr Canc Netw 2011;9:665-673.
2. Centers for Disease Control and Prevention. Tobacco use among middle and high school students-United States, 2000-2009. MMWR 2010;59:1063-1068.
3. Gillison ML, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-420.
4. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-1956.
5. Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29:4294-4301.
6. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet 2004;363:1488-1489.
7. Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344:1125-1131.
8. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
9. Centers for Disease Control and Prevention. Human papillomavirus vaccine. Available at http://www.cdc.gov/vaccinesafety/Vaccines/HPV. Accessed October 12, 2011.
10. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
11. Kreimer AR, Clifford GM, Boyle P et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-475.
12. Hansson BG, Rosenquist K, Antonsson A et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1337-1344.
13. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-3046.
14. Herrero A, Castellsagué X, Pawlita M et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-1783.
15. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-79.
16. Dyson N, Howley PM, Münger K et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-937.
17. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
18. Marur S, D'Souza G, Westra WH et al. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol 2010;11:781-789.
19. Allyn D. The sexual revolution: An unfettered history. Boston, MA: Little, Brown, 2000:1-367.
20. Bajos N, Bozon M, Beltzer N et al. Changes in sexual behaviours: From secular trends to public health policies. AIDS 2010;24:1185-1191.
21. Herbenick D, Reece M, Schick V et al. Sexual behavior in the United States: Results from a national probability sample of men and women ages 14-94. J Sex Med 2010;7:255-265.
22. Hammarstedt L, Lindquist D, Dahlstrand H et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-2623.
23. Näsman A, Attner P, Hammarstedt L et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362-366.
24. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-1435.
25. Gillison ML. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 2008;43:S52-S60.
26. Chaturvedi AK, Engels EA, Anderson WF et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-619.
27. Vidal L, Gillison ML. Human papillomavirus in HNSCC: Recognition of a distinct disease type. Hematol Oncol Clin North Am 2008;22:1125-1142.
28. Forte T, Niu J, Lockwood GA et al. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada. Cancer Causes Control 2012;23:1343-1348.
29. De Boer MF, McCormick LK, Pruyn JF et al. Physical and psychosocial correlates of head and neck cancer: A review of the literature. Otolaryngol Head Neck Surg 1999;120:427-436.
30. Kugaya A, Akechi T, Okuyama T et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000;88:2817-2223.
31. Verdonick-de Leeuw IM, de Bree R, Keizer AL et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 2009;45:e129-e133.
32. Mast TC, Zhu X, Demuro-Mercon C et al. Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin 2009;25:2609-2619.
33. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2007;120:885-891.
34. Maggino T, Casadei D, Panontin E et al. Impact of an HPV diagnosis on the quality of life in young women. Gynecol Oncol 2007;107:S175-S179.
35. Clarke P, Ebel C, Catotti DN et al. The psychosocial impact of human papillomavirus infection: Implications for health care providers. Int J STD AIDS 1996;7:197-200.
36. McCaffery K, Waller J, Nazroo J et al. Social and psychological impact of HPV testing in cervical screening: A qualitative study. Sex Transm Infect 2006;82:169-174.
37. Kwan TT, Cheung AN, Lo SS et al. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: A prospective study. Acta Obstet Gynecol Scand 2011;90:445-451.
38. Daley EM, Perrin KM, McDermott RJ et al. The psychosocial burden of HPV: A mixed-method study of knowledge, attitudes and behaviors among HPV women. J Health Psychol 2010;15:279-290.
39. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: A systematic review. Prev Med 2008;46:87-98.
40. Dillard JP, Spear ME. Knowledge of human papillomavirus and perceived barriers to vaccination in a sample of U.S. female college students. J Am Coll Health 2011;59:186-190.
41. Almeida CM, Tiro JA, Rodriguez MA et al. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine 2012;19:3003-3008.
42. Fernandez ME, McCurdy SA, Arvey SR et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health 2009;14:607-624.
43. Fortenberry JD. The effects of stigma on genital herpes care-seeking behaviours. Herpes 2004; 11:8-11.
44. Fortenberry JD, McFarlane M, Bleakley A et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health 2002;92: 378-381.
45. Waller J, McCaffery K, Kitchener H et al. Women's experiences of repeated HPV testing in the context of cervical cancer screening: A qualitative study. Psychooncology 2007;16:196-204.
46. Anhang R, Goodman S, Goldie SJ. HPV communication: Review of existing research and recommendations for patient education. CA Cancer J Clin 2004;54:248-259.
47. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55:1-17.
48. Westra WH. Detection of human papillomavirus in clinical samples. Otolaryngol Clin North Am 2012;45:765-777.
49. Thomas J, Primeaux R. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 2012;16:91-99.
50. El-Naggar AM, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck 2012;34:459-461.
51. Agoston ES, Robinson SJ, Mehra KK et al. Polymerase chain reaction detection of HPV in squamous carcinoma of the oropharynx. Am J Clin Pathol 2010;134:36-41.
52. Anderson KS, Wong J, D'Souza G et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer 2011;104: 1896-1905.
53. Waterboer T, Dondog B, Michael KM et al. Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, Hepatitis C virus, and JC virus. Cancer Epidemiol Biomarkers Prev 2012;21:287-293.
54. Cameron JE, Snowhite IV, Chaturvedi AK et al. Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin Diagn Lab Immunol 2003;10:431-438.
55. Turner DO, Williams-Cocks SJ, Bullen R et al. High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: A pilot study. BMC Oral Health 2011;11:28.
56. Dunne EF, Friedman A, Datta SD et al. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011;53:S143-S152.
57. Gilbert LK, Alexander L, Grosshans JF et al. Answering frequently asked questions about HPV. Sex Transm Dis 2003;30:193-194.
58. Campisi G, Panzarella V, Giuliani M et al. Human papillomavirus: Its identity and controversial role in oral oncogenesis, premalignant and malignant lesions. Int J Oncol 2007;30:813-823.
59. Koskimaa HM, Waterboer T, Pawlita M et al. Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J Pediatr 2011;160:837-843.
60. Kero K, Rautava J, Syrjänen K et al. Human papillomavirus genotypes in male genitalia and their concordance among pregnant spouses participating in the Finnish Family HPV study. J Sex Med 2011; 8:2522-2531.
61. Widdice LE, Breland DJ, Jonte J et al. Human papillomavirus concordance in heterosexual couples. J Adolesc Health 2010;47:151-159.
62. Kellokoski JK, Syrjänen SM, Chang F et al. Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J Oral Pathol Med 1992;21:459-464.
63. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999;75:317-319.
64. Peixoto AP, Campos GS, Queiroz LB et al. Asymptomatic oral human papillomavirus (HPV) infection in women with a histopathologic diagnosis of genital HPV. J Oral Sci 2011;53:451-459.
65. Xavier SD, Bussoloti Filho I, de Carvalho JM et al. Prevalence of human papillomavirus (HPV) DNA in oral mucosa of men with anogenital HPV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:732-737.
66. Castro TM, Bussoloti Filho I, Nascimento VX et al. HPV detection in the oral and genital mucosa of women with positive histopathological exam for genital HPV, by means of the PCR. Braz J Otorhinolaryngol 2009;75:167-171.
67. D'Souza G, Agrawal Y, Halpern J et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199: 1263-1269.
68. Rintala M, Grénman S, Puranen M et al. Natural history of oral papillomavirus infections in spouses: A prospective Finnish HPV Family Study. J Clin Virol 2006;35:89-94.
69. Tokudome S, Suzuki S, Ichikawa H et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. Int J Cancer 2004;112:164.
70. Bleeker MC, Hogewoning CJ, Voorhorst FJ et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003;107:804-810.
71. Andrews E, Shores C, Hayes DN et al. Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couples. J Infect Dis 2009;200:882-887.
72. Human papillomavirus (HPV) oral transmission study in partners over time (HOTSPOT) (NCT01342978). Available at http://clinicaltrials.gov/ct2/show/NCT01342978. Accessed December 15, 2012.
73. Denis F, Hanz S, Alain S. Clearance, persistence and recurrence of HPV infection. Gynecol Obstet Fertil 2008;36:430-440.
74. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011;121:4593-4599.
75. Sudhoff HH, Schwarze HP, Winder D et al. Evidence for a causal association for HPV in head and neck cancers. Eur Arch Otorhinolaryngol 2011;268: 1541-1547.
76. Gillison ML, Broutian T, Pickard RK et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
77. D'Souza G, Fakhry C, Sugar EA et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007;121:143-150.
78. Ang KK, Harris J, Wheeler R et al. Human papil-lomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
79. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100:261-269.
80. Posner MR, Lorch JH, Goloubeva O et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: A subset analysis from an international phase III trial. Ann Oncol 2011;22: 1071-1077.
81. Gillison ML, Zhang Q, Jordan R et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30: 2102-2111.
82. Maxwell JH, Kumar B, Feng FY et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 2010;16:1226-1235.
83. Hafkamp HC, Manni JJ, Haesevoets A et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008;122:2656-2664.
84. Sikora AG, Morris LC, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surgery 2009;135:402-405.
85. Pfister D. Clinical practice guidelines in oncology, version 2.2011. Washington, DC: National Comprehensive Cancer Network, 2011.
86. Centers for Disease Control and Prevention. Recommendations for partner services program for HIV infection, syphilis, gonorrhea, and chlamydia infection. MMWR 2008;57:1-9.
87. Field N, Tanton C, Mercer CH et al. Testing for sexually transmitted infections in a population- based sexual health survey: Development of an acceptable ethical approach. J Med Ethics 2012;38: 380-382.
88. Kreimer AR, Chaturvedi AK. HPV-associated oropharyngeal cancers: Are they preventable? Cancer Prev Res 2011;4:1346-1349.